Benzinga - Mon, 08 Feb 2021 06:16:26 -0400
Benzinga - Fri, 05 Feb 2021 13:03:18 -0400
Benzinga - Fri, 05 Feb 2021 08:01:22 -0400
Benzinga - Fri, 05 Feb 2021 05:54:56 -0400
Benzinga - Thu, 04 Feb 2021 14:01:24 -0400
Benzinga - Thu, 04 Feb 2021 13:00:18 -0400
Benzinga - Thu, 04 Feb 2021 09:08:12 -0400
Benzinga - Thu, 04 Feb 2021 06:42:42 -0400
load more
Sector: Health Care.Industry: Biotechnology
Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in the US. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The clinical-Stage Programs of the company includes delivery of therapeutics through microcatheters which delivers a number of therapeutics to the ducts in the breast, the site of the majority of early breast cancers and fulvestrant Delivered through microcatheters which delivers fulvestrant as a potential treatment of ductal carcinoma in-situ (DCIS) and breast cancer. In addition, the company involves in the process of evaluating additional potential indications of endoxifen and other therapeutic candidates to treat breast conditions, including breast cancer.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-12
REV
Q4 2020Est.ActualSurprise
EPS
(EXPECTED)2021-03-25
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ATOSAtossa Therapeutics4.21%159.6M

Atossa Therapeutics Company Questions & Answers

Q

How do I buy Atossa Therapeutics (ATOS) stock?

A

You can purchase shares of Atossa Therapeutics (NASDAQ: ATOS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Atossa Therapeutics's (ATOS) main competitors?

A

Other companies in Atossa Therapeutics’s space includes: Celcuity (NASDAQ:CELC), DiaMedica Therapeutics (NASDAQ:DMAC) and GlycoMimetics (NASDAQ:GLYC).

Q

What is the target price for Atossa Therapeutics?

A

The latest price target for Atossa Therapeutics (NASDAQ: ATOS) was reported by Ascendiant Capital on 2020-09-17. The analyst firm set a price target for 7.00 expecting ATOS to rise to within 12 months (a possible 213.90% upside). 1 analyst firms have reported ratings in the last year.

Q

How much is Atossa Therapeutics (ATOS) stock ?

A

The stock price for Atossa Therapeutics (NASDAQ: ATOS) is $2.23 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Atossa Therapeutics (ATOS) dividend?

A

There are no upcoming dividends for Atossa Therapeutics.

Q

When is Atossa Therapeutics (NASDAQ:ATOS) reporting earnings?

A
Atossa Therapeutics’s Q1 earnings are confirmed from now on May 12, 2021.
Q

When is the upcoming split for ATOS?

A

There is no upcoming split for Atossa Therapeutics.